Background Background We have reported the
We have reported the advantageous clinical outcome of adding advantageous clinical outcome of adding cognitive therapy to medication in the cognitive therapy to medication in the prevention of relapse of bipolar disorder. prevention of relapse of bipolar disorder.
Aims Aims This 30 -month study compares
This 30 -month study compares the cost-effectiveness of cognitive therapy the cost-effectiveness of cognitive therapy with standard care. with standard care.
Method Method We randomly allocated103
We randomly allocated103 individuals with bipolar1disorder to individuals with bipolar1disorder to standard treatment and cognitive therapy standard treatment and cognitive therapy plus standard treatment. Service use and plus standard treatment. Service use and costs were measured at 3-month intervals costs were measured at 3-month intervals and cost-effectiveness was assessed using and cost-effectiveness was assessed using the net-benefit approach. the net-benefit approach.
Results

Results The group receiving cognitive
The group receiving cognitive therapy had significantly better clinical therapy had significantly better clinical outcomes.The extra costs were offset by outcomes.The extra costs were offset by reduced service use elsewhere.The reduced service use elsewhere.The probability of cognitive therapy being costprobability of cognitive therapy being costeffective was high and robustto different effective was high and robustto different therapy prices. therapy prices.
Conclusions Conclusions Combination of cognitive
Combination of cognitive therapy and mood stabilisers was superior therapy and mood stabilisers was superior to mood stabilisers alone in terms of to mood stabilisers alone in terms of clinical outcome and cost-effectiveness for clinical outcome and cost-effectiveness for those with frequent relapses of bipolar those with frequent relapses of bipolar disorder. disorder.
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Bipolar disorder, characterised by frequent Bipolar disorder, characterised by frequent relapses, imposes a high economic burden relapses, imposes a high economic burden on society (Rice & Miller, 1995 ; Gupta on society (Rice & Miller, 1995; Gupta & Guest, 2002; Patel, 2003) . In our study & Guest, 2002; Patel, 2003) . In our study of relapse prevention (Lam of relapse prevention (Lam et al et al, 2003 (Lam et al et al, , , 2003 (Lam et al et al, , 2005 , the group receiving cognitive 2005), the group receiving cognitive therapy had significantly better clinical therapy had significantly better clinical outcomes than those receiving standard outcomes than those receiving standard National Health Service (NHS) care. HowNational Health Service (NHS) care. However, the cost of such intervention should be ever, the cost of such intervention should be evaluated in the context of other NHS evaluated in the context of other NHS services used. An economic evaluation will services used. An economic evaluation will enable healthcare providers to make proenable healthcare providers to make procurement and policy decisions. This paper curement and policy decisions. This paper reports health economic data for the first reports health economic data for the first 12 months (when patients were receiving 12 months (when patients were receiving cognitive therapy and up to two booster cognitive therapy and up to two booster sessions), as well as for the whole 30-month sessions), as well as for the whole 30-month study period. It is hypothesised that cognistudy period. It is hypothesised that cognitive therapy may be cost-effective because tive therapy may be cost-effective because the costs may be offset by the less-frequent the costs may be offset by the less-frequent use of other NHS services. use of other NHS services.
METHOD METHOD Procedure Procedure
The details of the study have been reported The details of the study have been reported elsewhere (Lam elsewhere (Lam et al et al, 2003 (Lam et al et al, , 2005 . Only a , 2003 Only a , , 2005 . Only a summary of the procedure will be given summary of the procedure will be given here. After the study had been fully exhere. After the study had been fully explained to participants, written informed plained to participants, written informed consent was obtained. Those who fulfilled consent was obtained. Those who fulfilled the study criteria were randomly allocated the study criteria were randomly allocated to cognitive therapy ( to cognitive therapy (n n¼51) or the compar-51) or the comparison group (treatment as usual; ison group (treatment as usual; n n¼52) using 52) using sequentially numbered and sealed opaque sequentially numbered and sealed opaque envelopes. The allocation sequence was envelopes. The allocation sequence was generated by a computer program prior to generated by a computer program prior to recruitment. The cognitive therapists were recruitment. The cognitive therapists were all clinical psychologists. Independent all clinical psychologists. Independent assessors, who were masked to the group assessors, who were masked to the group status, performed assessments every 6 status, performed assessments every 6 months to collect information on primary months to collect information on primary clinical outcomes and resource usage. clinical outcomes and resource usage.
Participants Participants
Participants, aged 18-70 years, were outParticipants, aged 18-70 years, were outpatients of the Maudsley and Bethlem patients of the Maudsley and Bethlem NHS Trust with DSM-IV bipolar I disorder NHS Trust with DSM-IV bipolar I disorder (American Psychiatric Association, 1994) . (American Psychiatric Association, 1994 In order to identify a sub-group vulnerable In order to identify a sub-group vulnerable to relapses, participants had to have had at to relapses, participants had to have had at least two episodes in the previous 2 years or least two episodes in the previous 2 years or three episodes in the previous 5 years. three episodes in the previous 5 years. Exclusion criteria were: actively suicidal Exclusion criteria were: actively suicidal (BDI suicide item scored 3) and currently (BDI suicide item scored 3) and currently fulfilling criteria for substance use disfulfilling criteria for substance use disorders. There were no significant differorders. There were no significant differences between the two groups in any of ences between the two groups in any of the initial demographic characteristics or the initial demographic characteristics or clinical features (Table 1) . clinical features (Table 1) .
Assessment and primary clinical Assessment and primary clinical outcome outcome
The Structured Clinical Instrument for The Structured Clinical Instrument for DSM-IV (SCID; First DSM-IV (SCID; First et al et al, 1996) was used , 1996) was used to determine any episode that fulfilled to determine any episode that fulfilled DSM-IV criteria for major depression, DSM-IV criteria for major depression, mania or hypomania. The number of days mania or hypomania. The number of days with bipolar episodes was defined as days with bipolar episodes was defined as days during which individuals fulfilled DSM-IV during which individuals fulfilled DSM-IV criteria for bipolar episodes from the SCID criteria for bipolar episodes from the SCID interview. Hospital computerised records interview. Hospital computerised records were used to confirm the exact length of were used to confirm the exact length of hospital stays. hospital stays.
Service utilisation Service utilisation
Participants were interviewed using the Participants were interviewed using the Client Service Receipt Inventory (CSRI; Client Service Receipt Inventory (CSRI; Beecham & Knapp, 2001 ) at baseline and Beecham & Knapp, 2001) at baseline and at 3-monthly follow-up visits. The CSRI at 3-monthly follow-up visits. The CSRI asks about specific health and social care asks about specific health and social care service use. Services measured included service use. Services measured included contacts with mental healthcare services contacts with mental healthcare services (psychiatrists, psychologists, community (psychiatrists, psychologists, community mental health nurses, day centres, counselmental health nurses, day centres, counsellors and other therapists), general practilors and other therapists), general practitioners, social workers, hospital services tioners, social workers, hospital services (out-patient care, day hospital contacts (out-patient care, day hospital contacts Cost-effectiveness of relapse-prevention cognitive Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30 -month study therapy for bipolar disorder: 30 -month study and accident and emergency attendances), and accident and emergency attendances), support groups and residential care. support groups and residential care. Details of in-patient stays for mental Details of in-patient stays for mental health and physical health reasons and health and physical health reasons and medication were checked from case notes. medication were checked from case notes. Medication use was only recorded every 6 Medication use was only recorded every 6 months, and therefore it was assumed that months, and therefore it was assumed that the same level of medication was used in the same level of medication was used in the 3 months prior to this. the 3 months prior to this.
Service costs Service costs
Unit and hospital costs (which aim to Unit and hospital costs (which aim to reflect the long-term marginal costs) for reflect the long-term marginal costs) for most services were obtained from a recogmost services were obtained from a recognised national source (Netten & Curtis, nised national source (Netten & Curtis, 2000) , where staff costs are calculated by 2000), where staff costs are calculated by dividing the total cost (salary, oncosts, dividing the total cost (salary, oncosts, overheads, capital, land and training) overheads, capital, land and training) of the service over 1 year by an of the service over 1 year by an appropriate unit of activity. Medication appropriate unit of activity. Medication costs were taken from the costs were taken from the British National British National Formulary Formulary (British Medical Association & (British Medical Association & Royal Pharmaceutical Society of Great BritRoyal Pharmaceutical Society of Great Britain, 2001 ). The cost of a cognitive therapy ain, 2001). The cost of a cognitive therapy session was assumed to be equal to 1 h of session was assumed to be equal to 1 h of a psychologist's time (£61). Unit costs were a psychologist's time (£61). Unit costs were multiplied by the service utilisation data to multiplied by the service utilisation data to generate service costs per patient. generate service costs per patient.
Statistical analyses Statistical analyses
Clinical outcome Clinical outcome
The main clinical outcome (days with biThe main clinical outcome (days with bipolar episodes), which was a continuous polar episodes), which was a continuous scale, was assessed for group differences scale, was assessed for group differences using a multivariate analysis of covariance, using a multivariate analysis of covariance, covarying the number of previous bipolar covarying the number of previous bipolar episodes and medication compliance. All episodes and medication compliance. All analyses were on an intention-to-treat analyses were on an intention-to-treat basis. The primary measure of costbasis. The primary measure of costeffectiveness was the number of bipolareffectiveness was the number of bipolarfree days (days without a bipolar episode) free days (days without a bipolar episode) in the period following randomisation to in the period following randomisation to 12-month and 30-month follow-up. Bi-12-month and 30-month follow-up. Bipolar episodes are not a sensitive measure polar episodes are not a sensitive measure of relapse prevention, as they can vary of relapse prevention, as they can vary tremendously in length. tremendously in length.
Resource use data Resource use data
Comparisons were made between the Comparisons were made between the cognitive therapy and comparison groups cognitive therapy and comparison groups for for use of community services (i.e. use of community services (i.e. non-innon-in-patient services combined), psychipatient services combined), psychiatric in-patient care, general in-patient care atric in-patient care, general in-patient care and medication. Tests of significance were and medication. Tests of significance were only conducted when comparing total costs only conducted when comparing total costs for each of the 3-month time periods. for each of the 3-month time periods.
Hospital use and medication data were Hospital use and medication data were available for most participants. Inforavailable for most participants. Information on the use of community services mation on the use of community services was less complete. Where missing, the cost was less complete. Where missing, the cost of community services was imputed by of community services was imputed by taking the mean of the costs for the other taking the mean of the costs for the other time periods. time periods.
Total cost differences between the Total cost differences between the groups were tested for statistical signifigroups were tested for statistical significance using a regression model with cost cance using a regression model with cost as the dependent variable and the group inas the dependent variable and the group indicator as the independent variable. Regresdicator as the independent variable. Regression analysis allowed us to deal with the sion analysis allowed us to deal with the expected non-normality of the costs disexpected non-normality of the costs distribution. Non-parametric bootstrapping tribution. Non-parametric bootstrapping with 1000 resamples was used to address with 1000 resamples was used to address the skewness in the cost data (Mooney & the skewness in the cost data (Mooney & Duval, 1993) . Confidence intervals were Duval, 1993). Confidence intervals were constructed at the 90% level because we constructed at the 90% level because we assumed that it is more acceptable to make assumed that it is more acceptable to make a type II error with economic data than a type II error with economic data than with clinical data. with clinical data.
Cost-effectiveness analysis Cost-effectiveness analysis
The incremental cost-effectiveness of cogniThe incremental cost-effectiveness of cognitive therapy compared with standard care tive therapy compared with standard care was determined using the net-benefit was determined using the net-benefit approach (Briggs, 2001 ). There is theoretiapproach (Briggs, 2001 ). There is theoretical, but unknown, value (represented by cal, but unknown, value (represented by the term the term l l below) that society would place below) that society would place on a 1-unit improvement in outcome, as on a 1-unit improvement in outcome, as measured by the number of bipolar-free measured by the number of bipolar-free days. The net benefit to society of cognitive days. The net benefit to society of cognitive therapy can be defined as: therapy can be defined as: NB NB¼( (l l6 6E) E)7 7SC, SC, where NB where NB¼net benefit, E net benefit, E¼effectiveness (i.e. effectiveness (i.e. days free of bipolar episodes over 12 and 30 days free of bipolar episodes over 12 and 30 months) and SC months) and SC¼service costs. For examservice costs. For example, if a bipolar-free day is assumed to have ple, if a bipolar-free day is assumed to have a value of £10 and if a particular individual a value of £10 and if a particular individual has 50 of these, then their has 50 of these, then their gross gross benefit is benefit is £500. However, it is assumed that is £500. However, it is assumed that is achieved at a cost, and if that is, say, achieved at a cost, and if that is, say, £300 then a net benefit of £200 is achieved. £300 then a net benefit of £200 is achieved. The trial provided us with data on effectiveThe trial provided us with data on effectiveness and service costs. Therefore to estiness and service costs. Therefore to estimate a net benefit for each individual we mate a net benefit for each individual we had to make an assumption regarding the had to make an assumption regarding the level of level of l l. . We estimated net benefits for all partiWe estimated net benefits for all participants by assuming different values for cipants by assuming different values for l l ranging between £0 and £50 in £10 increranging between £0 and £50 in £10 increments. A regression model was then used ments. A regression model was then used to determine the mean difference in net to determine the mean difference in net benefit between the cognitive therapy and benefit between the cognitive therapy and standard care (treatment as usual) groups standard care (treatment as usual) groups for every value of for every value of l l, controlling for baseline , controlling for baseline costs. For each model, 1000 regression costs. For each model, 1000 regression coefficients for the cognitive therapy/standcoefficients for the cognitive therapy/standard care variable were generated using ard care variable were generated using 5 01 5 01 bootstrapping, and the proportion of these bootstrapping, and the proportion of these greater than zero indicated the probability greater than zero indicated the probability that cognitive therapy was cost-effective that cognitive therapy was cost-effective (i.e. resulted in a mean incremental net (i.e. resulted in a mean incremental net benefit greater than zero) for that value of benefit greater than zero) for that value of l l. These probabilities were subsequently . These probabilities were subsequently used to generate a cost-effectiveness used to generate a cost-effectiveness acceptability curve. acceptability curve.
Sensitivity analysis Sensitivity analysis
The only addition to the standard package The only addition to the standard package of care was sessions of cognitive therapy. of care was sessions of cognitive therapy. The unit cost of this was based on that The unit cost of this was based on that for a clinical psychologist from a national for a clinical psychologist from a national source. However, it may be that the actual source. However, it may be that the actual unit cost could be different if other prounit cost could be different if other professionals (such as mental health nurses) fessionals (such as mental health nurses) provide the service, if more or less experiprovide the service, if more or less experienced psychologists deliver the service or enced psychologists deliver the service or if differences in supervision and general if differences in supervision and general infrastructure affect the costs. To take into infrastructure affect the costs. To take into account such possibilities we recalculated account such possibilities we recalculated the total costs by assuming that (i) the unit the total costs by assuming that (i) the unit cost of cognitive therapy was 50% lower cost of cognitive therapy was 50% lower (£30.50 per hour) and (ii) 50% higher (£30.50 per hour) and (ii) 50% higher (£91.50 per hour). (£91.50 per hour). 95.3; 95% CI of difference 32-189 days) with bipolar CI of difference 32-189 days) with bipolar episodes out of about 900 days in total. The episodes out of about 900 days in total. The differences were significant after controldifferences were significant after controlling for the number of previous bipolar ling for the number of previous bipolar episodes and medication compliance. The episodes and medication compliance. The actuarial cumulative relapse rates for actuarial cumulative relapse rates for bipolar episodes in the cognitive therapy bipolar episodes in the cognitive therapy and comparison groups were 64% (30/47) and comparison groups were 64% (30/47) and 84% (43/51), respectively. After and 84% (43/51), respectively. After controlling for the previous number of controlling for the previous number of episodes and medication compliance during episodes and medication compliance during the whole 30 months, the differences were the whole 30 months, the differences were significant for bipolar episodes (hazard significant for bipolar episodes (hazard ratio ratio¼0.50, 95% CI 0. Table 2 summarises service use for the cog- Table 2 summarises service use for the cognitive therapy and comparison groups in nitive therapy and comparison groups in the 3 months prior to baseline and each the 3 months prior to baseline and each follow-up assessment. During the 3 months follow-up assessment. During the 3 months prior to randomisation (baseline), 14% prior to randomisation (baseline), 14% (7/51) of the cognitive therapy group (7/51) of the cognitive therapy group received psychiatric in-patient treatment received psychiatric in-patient treatment and 16% (8/52) of the comparison group; and 16% (8/52) of the comparison group; 92% of individuals also received some 92% of individuals also received some community services. Virtually all particicommunity services. Virtually all participants were prescribed medication. pants were prescribed medication.
RESULTS RESULTS
Summary
Service utilisation Service utilisation
There were few differences in the proThere were few differences in the proportions of those using these groups of portions of those using these groups of services in the follow-up periods. However, services in the follow-up periods. However, in the 3 months preceding the 6-and 9-in the 3 months preceding the 6-and 9-month follow-up assessments, around twice month follow-up assessments, around twice as many from the comparison group were as many from the comparison group were admitted compared with those receiving admitted compared with those receiving cognitive therapy. However, this was recognitive therapy. However, this was reversed in the period before the 18-month versed in the period before the 18-month follow-up. Community services continued follow-up. Community services continued to be used by the majority of participants to be used by the majority of participants throughout the study. Medication also conthroughout the study. Medication also continued to be used by many, but the numbers tinued to be used by many, but the numbers did decline slightly. did decline slightly. Table 3 shows the average costs at baseline Table 3 shows the average costs at baseline and for each follow-up period. There was and for each follow-up period. There was much variation in resource use throughout much variation in resource use throughout the study period. Significance tests were the study period. Significance tests were only carried out on the difference between only carried out on the difference between the groups in total costs. For most periods, the groups in total costs. For most periods, there were no statistically significant differthere were no statistically significant differences; the exceptions were for the period up ences; the exceptions were for the period up to the 9-month assessment, when the cogto the 9-month assessment, when the cognitive therapy group was significantly less nitive therapy group was significantly less costly, and at the 18-month assessment, costly, and at the 18-month assessment, when the cognitive therapy group used sigwhen the cognitive therapy group used significantly more resources. These findings nificantly more resources. These findings were consistent with the clinical outcomes were consistent with the clinical outcomes (Lam (Lam et al et al, 2003 (Lam et al et al, , 2005 . , 2003, 2005) . The costs for the 12-and 30-month The costs for the 12-and 30-month periods following randomisation are periods following randomisation are shown in Table 4 . For the first 12 months shown in Table 4 . For the first 12 months of the study and the whole of the 30 of the study and the whole of the 30 5 0 2 5 0 2 Table 2  Table 2 Use of services during the 3 months prior to baseline and follow-up assessments Use of services during the 3 months prior to baseline and follow-up assessments CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU CT  CT TAU  TAU Psychiatric Psychiatric
Service cost Service cost
8 8 
3 3 (7)
7 7
(15)
6 6 (13)
4 4 (9)
6 6 (13) 
1 1
4 4
5 5
General General in-patient, in-patient, 
1 1 
1 1 5 0 3 5 0 3 Table 3  Table 3 Service costs (») for cognitive therapy and standard treatment groups during the 3 months prior to baseline and follow-up assessments Service costs (») for cognitive therapy and standard treatment groups during the 3 months prior to baseline and follow-up assessments months, the group receiving cognitive months, the group receiving cognitive therapy had lower service costs. However, therapy had lower service costs. However, the differences were not statistically the differences were not statistically significant. significant.
Cost-effectiveness analysis
Cost-effectiveness analysis Figure 1 shows cost-effectiveness accept- Figure 1 shows cost-effectiveness acceptability curves, which show the probability ability curves, which show the probability that cognitive therapy is more cost-effective that cognitive therapy is more cost-effective than standard care for a range of different than standard care for a range of different values placed on a day free of bipolar sympvalues placed on a day free of bipolar symptoms. Even with a zero value, the probabiltoms. Even with a zero value, the probability of cognitive therapy being cost-effective ity of cognitive therapy being cost-effective is in excess of 0.85 for the first 12 months is in excess of 0.85 for the first 12 months and 0.80 for the whole study period of 30 and 0.80 for the whole study period of 30 months. However, at a value of £10 and months. However, at a value of £10 and above per day free from bipolar episode, above per day free from bipolar episode, the probability of cognitive therapy being the probability of cognitive therapy being cost effective is in excess of 0.90 for the first cost effective is in excess of 0.90 for the first 12 months and 0.85 for the whole study 12 months and 0.85 for the whole study period of 30 months. period of 30 months.
Sensitivity analysis Sensitivity analysis
If the cost of the intervention is reduced by If the cost of the intervention is reduced by 50%, the total mean cost for the cognitive 50%, the total mean cost for the cognitive therapy group falls to £3952 over the 12-therapy group falls to £3952 over the 12-month period following randomisation month period following randomisation but if the cost is increased by 50% the mean but if the cost is increased by 50% the mean rises to £4815. These changes represent a rises to £4815. These changes represent a 10% shift in the average cost. Over the 10% shift in the average cost. Over the 30-month follow-up period the total cost 30-month follow-up period the total cost for the cognitive therapy group falls to for the cognitive therapy group falls to £9925 with the lower unit cost and in-£9925 with the lower unit cost and increases to £10 729 with the upper bound. creases to £10 729 with the upper bound. This represents a smaller proportional shift This represents a smaller proportional shift (4%). (4%). Figure 2 shows the impact of these new Figure 2 shows the impact of these new costs on the cost-effectiveness acceptability costs on the cost-effectiveness acceptability curves. For clarity only the most extreme curves. For clarity only the most extreme results are shown. The best result for cogniresults are shown. The best result for cognitive therapy is where the therapy cost is tive therapy is where the therapy cost is lower by 50% and the outcomes and costs lower by 50% and the outcomes and costs 5 0 4 5 0 4 (353) 77 (298) 77 (298) 248 (1273) 248 (1273) 183 (602) 183 (602) Community services Community services 1263 (1487) 1263 (1487) 1974 (2218) 1974 (2218) 3178 (3142) 3178 (3142) 4921 (6169) 4921 (6169) Medication Medication 419 (600) 419 (600) 338 (496) 338 (496) 921 (1017) 921 (1017) 680 (1015) 680 (1015) Total Total 4383 (5264) 4383 (5264) 5356 (6599) 5356 ( are measured only for the first 12 months. are measured only for the first 12 months. In this situation there is a 93% chance that In this situation there is a 93% chance that cognitive therapy is more cost-effective cognitive therapy is more cost-effective than standard NHS care even if a zero value than standard NHS care even if a zero value is placed on a bipolar-free day. The worst is placed on a bipolar-free day. The worst case for cognitive therapy is with therapy case for cognitive therapy is with therapy costs raised by 50% and outcomes and costs raised by 50% and outcomes and costs measured over the longer period of costs measured over the longer period of 30 months. Even here there is a 75.2% 30 months. Even here there is a 75.2% chance of cognitive therapy being the more chance of cognitive therapy being the more cost-effective option with a zero value cost-effective option with a zero value placed on a bipolar-free day, and the figure placed on a bipolar-free day, and the figure rapidly rises to more than 90% as the value rapidly rises to more than 90% as the value of a bipolar-free day increases. of a bipolar-free day increases.
DISCUSSION DISCUSSION
Clinical outcome Clinical outcome
In this study, the comparison group reIn this study, the comparison group received standard treatment, which consisted ceived standard treatment, which consisted of mood stabilisers and psychiatric followof mood stabilisers and psychiatric followup, and the other group received cognitive up, and the other group received cognitive therapy in addition to standard treatment. therapy in addition to standard treatment. Combination of cognitive therapy and Combination of cognitive therapy and mood stabilisers produced better clinical mood stabilisers produced better clinical outcomes, particularly in the first 12 outcomes, particularly in the first 12 months. However, as therapy became more months. However, as therapy became more distant, the effect of therapy was less robust distant, the effect of therapy was less robust (Lam (Lam et al et al, 2005) . , 2005).
Cost effectiveness Cost effectiveness
The group receiving cognitive therapy inThe group receiving cognitive therapy incurred £1000 less service costs for the first curred £1000 less service costs for the first 12 months and £1300 less over the whole 12 months and £1300 less over the whole 30 months. However, the difference in total 30 months. However, the difference in total service cost between the cognitive therapy service cost between the cognitive therapy and comparison group was not significant. and comparison group was not significant. As expected, the bulk of the service cost As expected, the bulk of the service cost was for psychiatric in-patient care. Psychiwas for psychiatric in-patient care. Psychiatric in-patient care was very expensive, atric in-patient care was very expensive, leading to highly skewed data. The analysis leading to highly skewed data. The analysis showed that cognitive therapy was highly showed that cognitive therapy was highly cost-effective compared with standard care cost-effective compared with standard care alone. Even if no value is placed on a alone. Even if no value is placed on a bipolar-free day, the probability of cognibipolar-free day, the probability of cognitive therapy being more cost-effective than tive therapy being more cost-effective than standard treatment was more than 80% standard treatment was more than 80% during the first year and the whole study during the first year and the whole study period of 30 months. The probability of period of 30 months. The probability of cognitive therapy being cost-effective was cognitive therapy being cost-effective was slightly lower if the whole 30-month period slightly lower if the whole 30-month period was considered. However, if society is was considered. However, if society is willing to attribute a value of even £5 to willing to attribute a value of even £5 to one bipolar-free day, the probability of one bipolar-free day, the probability of cognitive therapy being cost-effective incognitive therapy being cost-effective increases to beyond 85% for both time creases to beyond 85% for both time periods. There are very few costperiods. There are very few costeffectiveness analyses of interventions for effectiveness analyses of interventions for bipolar disorder; the few there are use bipolar disorder; the few there are use outcome measures and methods that differ outcome measures and methods that differ from the analyses presented here. from the analyses presented here. Comparisons Comparisons are not therefore possible. are not therefore possible. Finally, the probability of cognitive therapy Finally, the probability of cognitive therapy being more cost effective than standard being more cost effective than standard psychiatric care is robust in the sensitivity psychiatric care is robust in the sensitivity analysis. Even if the cost of cognitive theranalysis. Even if the cost of cognitive therapy is increased by 50% (from £863 to apy is increased by 50% (from £863 to £1295), the probability of cognitive therapy £1295), the probability of cognitive therapy being cost-effective is still high. being cost-effective is still high.
Clinical implications Clinical implications
Our results support the addition of cogniOur results support the addition of cognitive therapy for relapse prevention in bitive therapy for relapse prevention in bipolar disorder, particularly for those who polar disorder, particularly for those who are vulnerable to relapses despite the preare vulnerable to relapses despite the prescription of mood stabilisers. Clinically, scription of mood stabilisers. Clinically, the combined treatment was significantly the combined treatment was significantly more effective. The cost of adding cognitive more effective. The cost of adding cognitive therapy to the routine treatment with mood therapy to the routine treatment with mood stabilisers and psychiatric follow-up was stabilisers and psychiatric follow-up was offset by fewer costs for other services. offset by fewer costs for other services.
Limitations Limitations
There were a number of limitations in this There were a number of limitations in this study. First, data on service use were study. First, data on service use were collected using a self-report questionnaire. collected using a self-report questionnaire. Although this allows a far greater breadth Although this allows a far greater breadth of service use to be measured, it may not of service use to be measured, it may not be as accurate. However, the recall period be as accurate. However, the recall period was relatively short (3 months) and data was relatively short (3 months) and data on therapy and in-patient episodes were on therapy and in-patient episodes were collected from other sources. We did not collected from other sources. We did not address the reliability of the service use address the reliability of the service use measures. However, other studies have measures. However, other studies have found self-report to be an appropriate found self-report to be an appropriate way of measuring resource use (Calsyn way of measuring resource use (Calsyn et et al al, 1993; Goldberg , 1993; Goldberg et al et al, 2002) . Second, , 2002) . Second, although a broad range of services was inalthough a broad range of services was included, there were others that were not cluded, there were others that were not measured, such as informal care from measured, such as informal care from family and friends; also participant time family and friends; also participant time was not costed. Third, we did not have was not costed. Third, we did not have the health economy data prior to randomisthe health economy data prior to randomisation. However, there was no significant ation. However, there was no significant difference between the two groups in terms difference between the two groups in terms of previous hospitalisation, which incurred of previous hospitalisation, which incurred most of the health costs. Finally, the study most of the health costs. Finally, the study showed that cognitive therapy had a high showed that cognitive therapy had a high probability of being cost-effective but of probability of being cost-effective but of course it is unknown what value society course it is unknown what value society places on this. However, the cost-effectiveplaces on this. However, the cost-effectiveness acceptability curves do show the range ness acceptability curves do show the range The cost of a course of cognitive therapy is offset by lower costs for other services.
& & Even if the cost of cognitive therapy is increased by 50% (from »863 to »1295), the Even if the cost of cognitive therapy is increased by 50% (from »863 to »1295), the probability of cognitive therapy being cost-effective is still high. probability of cognitive therapy being cost-effective is still high.
LIMITATIONS LIMITATIONS
& & There was no protocol for standard NHS treatment. Decisions on drugs and There was no protocol for standard NHS treatment. Decisions on drugs and frequency of psychiatric follow-up were left to the clinicians responsible for day-tofrequency of psychiatric follow-up were left to the clinicians responsible for day-today care. day care. There is no general agreement on the value of a bipolar-free day. of values beyond which further increases of values beyond which further increases have a negligible impact on the probability. have a negligible impact on the probability. Although valuing a bipolar-free day may Although valuing a bipolar-free day may have more practical meaning than valuing have more practical meaning than valuing a point change on a particular outcome a point change on a particular outcome scale, it is still a rather nebulous concept. scale, it is still a rather nebulous concept. Further research should be conducted to deFurther research should be conducted to determine the views of users, family members termine the views of users, family members and clinicians as to whether bipolar-free and clinicians as to whether bipolar-free days are meaningful as an outcome measure days are meaningful as an outcome measure and, if so, exactly how they might be and, if so, exactly how they might be valued. valued.
